Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy. Biomol Biomed [Internet]. 2025 Apr. 3 [cited 2025 May 2];25(5):1099–1110. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11217